As a global leading CRO to support clinical development, CD BioSciences offers the entire process of bringing a new drug, device or diagnostic kit to the market. We are dedicated to all clinical phases including bioanalytical testing, clinical pharmacology, early phase trials, late phase trials and clinical data management, analysis & reporting.
Over the past decades, the development of monoclonal therapeutic antibody has grown exponentially. Great achievement has been made for the treatment of diseases such as cancer, arthritis, psoriasis, transplant rejection etc. Also, a variety of new engineering technologies to improve the safety and efficacy of therapeutic antibody have been developed and established. In 2015, the global market for monoclonal therapeutic antibodies accounted for about 85 billion USD, and it is expected to be higher in the near future. The market prospect indicates that the development of therapeutic antibody drug is an important and attractive direction.
Fig.1 Monoclonal antibodies market, 2013-2014 (USD Billion).
Clinical Development Solutions for Therapeutic Antibody
To support your therapeutic antibody drug development and market approval, CD BioSciences offers end-to-end clinical trial development services to speed your antibody drug development. Our entire clinical development solutions include bioanalytical lab testing, clinical pharmacology service, early phase clinical trials, late phase clinical trials and data management, analysis and reporting. With the successful experience in clinical design, execution, our team is confident to assist you with your drug program every step of the way. No matter if you need a stand-alone module, or a full-service package to outsource your drug clinical development program, we can customize the solutions to best meet your needs. Your drug market approval is our final goal. We are committed to partnering with you to provide accurate, high-quality clinical data, facilitating your smarter decisions in every stage.
Explore Our Capabilities
CD BioSciences offers end-to-end, full-service, fit-for-purpose clinical services to advance your drug clinical development, accelerate the market approval, and maximize the success of your program. To find out more services, please reach out to our experts for assistance.
CD BioSciences offers comprehensive suite of clinical development services to address big challenges for the complexities of therapeutic antibody drug. With experienced professionals, advanced systems, state-of-the-art infrastructures, we are dedicated to providing the highest level of entire program management and clinical trial development services, accelerating the market approval for your monoclonal therapeutic antibody drug. To find out more services, please contact us.